XML 49 R37.htm IDEA: XBRL DOCUMENT
v3.24.3

Derivative Liabilities (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
Derivative Liabilities [Line Items] |
Schedule of Common Stock Purchase Derivative Liability Warrants | A continuity of the Company’s common stock purchase derivative liability warrants is as follows:
|  | Derivative liabilities |
Outstanding, December 31, 2022 |  | $ | 68,455 |
Addition of new derivatives during IPO |  |  | 229,437 |
Change in fair value of derivative liabilities |  |  | 71,266 |
Outstanding, December 31, 2023 |  | $ | 369,158 |
Change in fair value of derivative liabilities |  |  | (367,277 | )
Outstanding, September 30, 2024 |  | $ | 1,881 |
Schedule of Black-Scholes Option Pricing Model | The following assumptions were used in the Black-Scholes option pricing model:
|  | Initial recognition |
Risk-free interest rate |  | 5.12-5.44% |
Expected life |  | 0.5-1 years |
Expected dividend rate |  | 0.00% |
Expected volatility |  | 100% |
Derivative liabilities [Member] |
Derivative Liabilities [Line Items] |
Schedule of Black-Scholes Option Pricing Model | The following assumptions were used in the Black-Scholes option pricing model:
|  | September 30, 2024 |  |  | December 31, 2023 |  |  | November 21, 2023 |  |  | December 31, 2022 |  |  | July 15, 2022 |
Risk-free interest rate |  |  | 3.58 | % |  |  | 3.84 - 4.01% |  |  |  | 4.41 | % |  |  | 4.73 | % |  |  | 3.12 | %
Expected life 1 |  |  | 2.57 – 4.15 years |  |  |  | 3.32 – 4.90 years |  |  |  | 5 years |  |  |  | 0.75 years |  |  |  | 0.6 years |
Expected dividend rate |  |  | 0 | % |  |  | 0 | % |  |  | 0.00 | % |  |  | 0.00 | % |  |  | 0.00 | %
Expected volatility |  |  | 100 | % |  |  | 100 | % |  |  | 100 | % |  |  | 100 | % |  |  | 100 | %
| 1 | On April 28, 2023, the Company amended the warrant agreements for the 231,828 derivative liability warrants outstanding. The amendment removed the clause to automatically convert warrants to shares on IPO date and all warrants were given an expiry date of April 27, 2027. This led to an increase in the expected life input in the Black-Scholes model as of December 31, 2023, compared to December 31, 2022, when the Company used the expected IPO date to calculate the expected life of the warrants.
Schedule of Derivative Liability Warrants Outstanding | As of September 30, 2024, the following derivative liability warrants were outstanding:
Outstanding |  |  | Expiry date1 |  | Weighted average exercise price ($) |
| 75,840 |  |  | April 27, 2027 |  |  | 2.01 |
| 63,037 |  |  | April 27, 2027 |  |  | 2.01 |
| 80,388 |  |  | April 27, 2027 |  |  | 2.01 |
| 12,563 |  |  | April 27, 2027 |  |  | 2.01 |
| 75,000 |  |  | November 21, 2028 |  |  | 4.00 |
| 306,828 |  |  |  |  |  | 2.50 |
| 1 | On April 28, 2023, the Company amended the warrant agreements for the 231,828 derivative liability warrants outstanding. The amendment removed the clause to automatically convert warrants to shares on IPO date and all warrants were given an expiry date of April 27, 2027. This led to an increase in the expected life input in the Black-Scholes model as of December 31, 2023, compared to December 31, 2022, when the Company used the expected IPO date to calculate the expected life of the warrants.

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5 + Details
Name: | us-gaap_DerivativeLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of derivative liabilities at fair value. + References No definition available. + Details
Name: | us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |